US gov­ern­ment to ac­quire $138M worth of Tpoxx dos­es

Siga Tech­nolo­gies said Thurs­day that the US has or­dered $113 mil­lion of the com­pa­ny’s oral Tpoxx treat­ment cours­es and $25 mil­lion of the in­tra­venous ver­sion of the same drug.

Tpoxx, al­so known as tecovir­i­mat, is a small mol­e­cule used to treat small­pox. It was first ap­proved in 2018, and the IV ver­sion re­ceived FDA ap­proval last year. Siga plans to de­liv­er the oral dos­es with­in the year, and it ex­pects to start de­liv­er­ing the IV dos­es in 2024.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER